# EDGAR Filing Document

**Accession Number:** 0001485894
**File Stem:** 0001752724-23-066064
**Filing Date:** 2023-3
**Character Count:** 50111
**Document Hash:** 21452d8cd717bb46a66b95bfa5424f0d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-23-066064.hdr.sgml**: 20230327

**ACCESSION NUMBER**: 0001752724-23-066064

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230131

**FILED AS OF DATE**: 20230327

**DATE AS OF CHANGE**: 20230327

**PERIOD START**: 20231031

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** J.P. Morgan Exchange-Traded Fund Trust
- **CENTRAL INDEX KEY:** 0001485894
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-22903
- **FILM NUMBER:** 23761650

**BUSINESS ADDRESS:**
- **STREET 1:** 277 PARK AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10172
- **BUSINESS PHONE:** (800) 480-4111

**MAIL ADDRESS:**
- **STREET 1:** 277 PARK AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10172

## Series and Classes Contracts Data

### JPMorgan Social Advancement ETF (Series ID: S000076156)

| Class ID   | Class Name                      | Ticker Symbol   |
|:---|:---|:---|
| C000235629 | JPMorgan Social Advancement ETF | UPWD            |

## Nport-Ex

**JPMorgan Social Advancement ETF**

**Schedule of Portfolio Investments as of January 31, 2023**

**(Unaudited)** 

---

| |
|:---|
| &nbsp;&nbsp; THE "UNAUDITED MUTUAL FUNDS HOLDINGS" LIST ("the <br> List") IS TO BE USED FOR REPORTING PURPOSES ONLY. IT IS <br> NOT TO BE REPRODUCED FOR USE AS ADVERTISING OR <br> SALES LITERATURE WITH THE GENERAL PUBLIC. The list is <br> submitted for the general information of the shareholders of the Fund. <br> It is not authorized for distribution to prospective investors in the Fund <br> unless preceded or accompanied by a prospectus. The list has been <br> created from the books and records of the Fund. Holdings are <br> available 60 days after the fund's fiscal quarter, using a trade date <br> accounting convention, by contacting the appropriate service center. <br> The list is subject to change without notice. The list is for <br> informational purposes only and is not intended as an offer or <br> solicitation with respect to the purchase or sale of any security.<br>|
| &nbsp;&nbsp; JPMorgan Asset Management is the marketing name for the asset <br> management business of J.P. Morgan Chase & Co.<br>|
| J.P. Morgan Distribution Services, Inc., member FINRA. |
|© J.P. Morgan Chase & Co., 2023. |

---

------

**JPMorgan Social Advancement ETF** <br>**SCHEDULE OF PORTFOLIO INVESTMENTS** <br>AS OF January 31, 2023 (Unaudited)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **INVESTMENTS** | **SHARES** | &nbsp;&nbsp;&nbsp; <br> **VALUE($)**<br>|
| **Common Stocks — 97.0%** | **Common Stocks — 97.0%** | **Common Stocks — 97.0%** |
| **Australia — 0.9%** | **Australia — 0.9%** | **Australia — 0.9%** |
| &nbsp;&nbsp;&nbsp; Stockland, REIT | 39708 | 110955 |
| **Belgium — 1.7%** | **Belgium — 1.7%** | **Belgium — 1.7%** |
| &nbsp;&nbsp;&nbsp; KBC Group NV | 2628 | 194649 |
| **Brazil — 1.2%** | **Brazil — 1.2%** | **Brazil — 1.2%** |
| &nbsp;&nbsp;&nbsp; Raia Drogasil SA | 28008 | 137659 |
| **China — 1.8%** | **China — 1.8%** | **China — 1.8%** |
| &nbsp;&nbsp;&nbsp; NXP Semiconductors NV | 1152 | 212325 |
| **Denmark — 2.4%** | **Denmark — 2.4%** | **Denmark — 2.4%** |
| &nbsp;&nbsp;&nbsp; Novo Nordisk A/S, Class B | 1991 | 275534 |
| **France — 3.2%** | **France — 3.2%** | **France — 3.2%** |
| &nbsp;&nbsp;&nbsp; Vinci SA | 3321 | 375238 |
| **Germany — 1.3%** | **Germany — 1.3%** | **Germany — 1.3%** |
| &nbsp;&nbsp;&nbsp; adidas AG | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 946 | &nbsp;&nbsp;&nbsp;&nbsp; 152321 |
| **Hong Kong — 1.3%** | **Hong Kong — 1.3%** | **Hong Kong — 1.3%** |
| &nbsp;&nbsp;&nbsp; AIA Group Ltd. | &nbsp;&nbsp; 13600 | &nbsp;&nbsp;&nbsp;&nbsp; 153784 |
| **India — 2.6%** | **India — 2.6%** | **India — 2.6%** |
| &nbsp;&nbsp;&nbsp; HDFC Bank Ltd., ADR | &nbsp;&nbsp;&nbsp;&nbsp; 4518 | &nbsp;&nbsp;&nbsp;&nbsp; 304333 |
| **Indonesia — 1.0%** | **Indonesia — 1.0%** | **Indonesia — 1.0%** |
| &nbsp;&nbsp;&nbsp; Bank Rakyat Indonesia Persero Tbk. PT | 376200 | &nbsp;&nbsp;&nbsp;&nbsp; 115368 |
| **Ireland — 2.1%** | **Ireland — 2.1%** | **Ireland — 2.1%** |
| &nbsp;&nbsp;&nbsp; Kerry Group plc, Class A | &nbsp;&nbsp;&nbsp;&nbsp; 1250 | &nbsp;&nbsp;&nbsp;&nbsp; 117125 |
| &nbsp;&nbsp;&nbsp; Kingspan Group plc | &nbsp;&nbsp;&nbsp;&nbsp; 2041 | &nbsp;&nbsp;&nbsp;&nbsp; 131269 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp; 248394 |
| **Italy — 1.9%** | **Italy — 1.9%** | **Italy — 1.9%** |
| &nbsp;&nbsp;&nbsp; FinecoBank Banca Fineco SpA | &nbsp;&nbsp; 12420 | &nbsp;&nbsp;&nbsp;&nbsp; 222962 |
| **Japan — 6.5%** | **Japan — 6.5%** | **Japan — 6.5%** |
| &nbsp;&nbsp;&nbsp; Katitas Co. Ltd. | &nbsp;&nbsp;&nbsp;&nbsp; 5400 | &nbsp;&nbsp;&nbsp;&nbsp; 132410 |
| &nbsp;&nbsp;&nbsp; LITALICO, Inc. | &nbsp;&nbsp;&nbsp;&nbsp; 3100 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 63286 |
| &nbsp;&nbsp;&nbsp; Recruit Holdings Co. Ltd. | &nbsp;&nbsp;&nbsp;&nbsp; 3800 | &nbsp;&nbsp;&nbsp;&nbsp; 122209 |
| &nbsp;&nbsp;&nbsp; T&D Holdings, Inc. | &nbsp;&nbsp;&nbsp;&nbsp; 9900 | &nbsp;&nbsp;&nbsp;&nbsp; 158462 |
| &nbsp;&nbsp;&nbsp; Tokio Marine Holdings, Inc. | &nbsp;&nbsp;&nbsp;&nbsp; 5400 | &nbsp;&nbsp;&nbsp;&nbsp; 113102 |
| &nbsp;&nbsp;&nbsp; Tokyo Electron Ltd. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 500 | &nbsp;&nbsp;&nbsp;&nbsp; 174762 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp; 764231 |
| **Mexico — 2.1%** | **Mexico — 2.1%** | **Mexico — 2.1%** |
| &nbsp;&nbsp;&nbsp; Wal-Mart de Mexico SAB de CV | &nbsp;&nbsp; 63621 | &nbsp;&nbsp;&nbsp;&nbsp; 248497 |
| **Netherlands — 7.4%** | **Netherlands — 7.4%** | **Netherlands — 7.4%** |
| &nbsp;&nbsp;&nbsp; ASML Holding NV | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 568 | &nbsp;&nbsp;&nbsp;&nbsp; 375816 |
| &nbsp;&nbsp;&nbsp; Koninklijke Ahold Delhaize NV | &nbsp;&nbsp;&nbsp;&nbsp; 8075 | &nbsp;&nbsp;&nbsp;&nbsp; 241014 |
| &nbsp;&nbsp;&nbsp; Koninklijke DSM NV | &nbsp;&nbsp;&nbsp;&nbsp; 1067 | &nbsp;&nbsp;&nbsp;&nbsp; 137219 |
| &nbsp;&nbsp;&nbsp; NN Group NV | &nbsp;&nbsp;&nbsp;&nbsp; 2520 | &nbsp;&nbsp;&nbsp;&nbsp; 109489 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp; 863538 |
| **Nigeria — 1.0%** | **Nigeria — 1.0%** | **Nigeria — 1.0%** |
| &nbsp;&nbsp;&nbsp; Airtel Africa plc (a) | &nbsp;&nbsp; 84262 | &nbsp;&nbsp;&nbsp;&nbsp; 121646 |

---

------

**JPMorgan Social Advancement ETF** <br>**SCHEDULE OF PORTFOLIO INVESTMENTS** <br>AS OF January 31, 2023 (Unaudited) (continued)

---

| | | |
|:---|:---|:---|
| **INVESTMENTS** | **SHARES** | &nbsp;&nbsp;&nbsp; <br> **VALUE($)**<br>|
| **Common Stocks — continued** | **Common Stocks — continued** | **Common Stocks — continued** |
| **Peru — 1.0%** | **Peru — 1.0%** | **Peru — 1.0%** |
| &nbsp;&nbsp;&nbsp; Credicorp Ltd. | 909 | 122079 |
| **Portugal — 1.5%** | **Portugal — 1.5%** | **Portugal — 1.5%** |
| &nbsp;&nbsp;&nbsp; Jeronimo Martins SGPS SA | 7874 | 170950 |
| **Puerto Rico — 0.5%** | **Puerto Rico — 0.5%** | **Puerto Rico — 0.5%** |
| &nbsp;&nbsp;&nbsp; EVERTEC, Inc. | 1737 | 64165 |
| **South Africa — 1.0%** | **South Africa — 1.0%** | **South Africa — 1.0%** |
| &nbsp;&nbsp;&nbsp; Vodacom Group Ltd. | 15838 | 111307 |
| **Switzerland — 0.7%** | **Switzerland — 0.7%** | **Switzerland — 0.7%** |
| &nbsp;&nbsp;&nbsp; Sika AG (Registered) | 274 | 77856 |
| **United Kingdom — 6.9%** | **United Kingdom — 6.9%** | **United Kingdom — 6.9%** |
| &nbsp;&nbsp;&nbsp; AstraZeneca plc | 1203 | 157608 |
| &nbsp;&nbsp;&nbsp; Reckitt Benckiser Group plc | &nbsp;&nbsp;&nbsp;&nbsp; 1557 | &nbsp;&nbsp;&nbsp;&nbsp; 110953 |
| &nbsp;&nbsp;&nbsp; RELX plc | &nbsp;&nbsp;&nbsp; 13046 | &nbsp;&nbsp;&nbsp;&nbsp; 387583 |
| &nbsp;&nbsp;&nbsp; Taylor Wimpey plc | 102781 | &nbsp;&nbsp;&nbsp;&nbsp; 149128 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp; 805272 |
| **United States — 47.0%** | **United States — 47.0%** | **United States — 47.0%** |
| &nbsp;&nbsp;&nbsp; AbbVie, Inc. | &nbsp;&nbsp;&nbsp;&nbsp; 1530 | &nbsp;&nbsp;&nbsp;&nbsp; 226058 |
| &nbsp;&nbsp;&nbsp; Alphabet, Inc., Class A \* | &nbsp;&nbsp;&nbsp;&nbsp; 2907 | &nbsp;&nbsp;&nbsp;&nbsp; 287328 |
| &nbsp;&nbsp;&nbsp; Analog Devices, Inc. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 909 | &nbsp;&nbsp;&nbsp;&nbsp; 155866 |
| &nbsp;&nbsp;&nbsp; Boston Scientific Corp. \* | &nbsp;&nbsp;&nbsp;&nbsp; 5329 | &nbsp;&nbsp;&nbsp;&nbsp; 246466 |
| &nbsp;&nbsp;&nbsp; Charles Schwab Corp. (The) | &nbsp;&nbsp;&nbsp;&nbsp; 2043 | &nbsp;&nbsp;&nbsp;&nbsp; 158169 |
| &nbsp;&nbsp;&nbsp; CSX Corp. | &nbsp;&nbsp;&nbsp;&nbsp; 2844 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 87936 |
| &nbsp;&nbsp;&nbsp; Deere & Co. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 612 | &nbsp;&nbsp;&nbsp;&nbsp; 258778 |
| &nbsp;&nbsp;&nbsp; Dollar General Corp. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 537 | &nbsp;&nbsp;&nbsp;&nbsp; 125443 |
| &nbsp;&nbsp;&nbsp; DR Horton, Inc. | &nbsp;&nbsp;&nbsp;&nbsp; 1845 | &nbsp;&nbsp;&nbsp;&nbsp; 182083 |
| &nbsp;&nbsp;&nbsp; Fiserv, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 1134 | &nbsp;&nbsp;&nbsp;&nbsp; 120975 |
| &nbsp;&nbsp;&nbsp; Intuitive Surgical, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 811 | &nbsp;&nbsp;&nbsp;&nbsp; 199255 |
| &nbsp;&nbsp;&nbsp; Lam Research Corp. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 304 | &nbsp;&nbsp;&nbsp;&nbsp; 152030 |
| &nbsp;&nbsp;&nbsp; M&T Bank Corp. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 690 | &nbsp;&nbsp;&nbsp;&nbsp; 107640 |
| &nbsp;&nbsp;&nbsp; Mastercard, Inc., Class A | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 747 | &nbsp;&nbsp;&nbsp;&nbsp; 276838 |
| &nbsp;&nbsp;&nbsp; Microsoft Corp. | &nbsp;&nbsp;&nbsp;&nbsp; 2248 | &nbsp;&nbsp;&nbsp;&nbsp; 557077 |
| &nbsp;&nbsp;&nbsp; NIKE, Inc., Class B | &nbsp;&nbsp;&nbsp;&nbsp; 1580 | &nbsp;&nbsp;&nbsp;&nbsp; 201181 |
| &nbsp;&nbsp;&nbsp; Pathward Financial, Inc. | &nbsp;&nbsp;&nbsp;&nbsp; 1854 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 91995 |
| &nbsp;&nbsp;&nbsp; Roche Holding AG | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 502 | &nbsp;&nbsp;&nbsp;&nbsp; 156710 |
| &nbsp;&nbsp;&nbsp; Skyline Champion Corp. \* | &nbsp;&nbsp;&nbsp;&nbsp; 2709 | &nbsp;&nbsp;&nbsp;&nbsp; 159696 |
| &nbsp;&nbsp;&nbsp; SLM Corp. | &nbsp;&nbsp;&nbsp;&nbsp; 5463 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 95985 |
| &nbsp;&nbsp;&nbsp; Sun Communities, Inc., REIT | &nbsp;&nbsp;&nbsp;&nbsp; 1233 | &nbsp;&nbsp;&nbsp;&nbsp; 193408 |
| &nbsp;&nbsp;&nbsp; Thermo Fisher Scientific, Inc. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 278 | &nbsp;&nbsp;&nbsp;&nbsp; 158552 |
| &nbsp;&nbsp;&nbsp; Union Pacific Corp. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 720 | &nbsp;&nbsp;&nbsp;&nbsp; 147017 |
| &nbsp;&nbsp;&nbsp; UnitedHealth Group, Inc. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 798 | &nbsp;&nbsp;&nbsp;&nbsp; 398354 |
| &nbsp;&nbsp;&nbsp; Vertex Pharmaceuticals, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 681 | &nbsp;&nbsp;&nbsp;&nbsp; 220031 |
| &nbsp;&nbsp;&nbsp; Visa, Inc., Class A | &nbsp;&nbsp;&nbsp;&nbsp; 1075 | &nbsp;&nbsp;&nbsp;&nbsp; 247476 |
| &nbsp;&nbsp;&nbsp; Waste Connections, Inc. | &nbsp;&nbsp;&nbsp;&nbsp; 2215 | &nbsp;&nbsp;&nbsp;&nbsp; 294374 |
|  |  | &nbsp;&nbsp; 5506721 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks <br>(Cost $10,311,762)<br>|  | 11359784 |

---

------

**JPMorgan Social Advancement ETF** <br>**SCHEDULE OF PORTFOLIO INVESTMENTS** <br>AS OF January 31, 2023 (Unaudited) (continued)

---

| | | |
|:---|:---|:---|
| **INVESTMENTS** | **SHARES** | &nbsp;&nbsp;&nbsp; <br> **VALUE($)**<br>|
| **Short-Term Investments — 2.5%** | **Short-Term Investments — 2.5%** | **Short-Term Investments — 2.5%** |
| **Investment Companies — 2.5%** | **Investment Companies — 2.5%** | **Investment Companies — 2.5%** |
| &nbsp;&nbsp;&nbsp; JPMorgan Prime Money Market Fund Class IM Shares, 4.52% (b) (c)(Cost $290,377) | 290307 | 290481 |
| **Total Investments — 99.5%** <br>**(Cost $10,602,139)**<br>|  | **11650265** |
| **Other Assets Less Liabilities — 0.5%** |  | **57218** |
| **NET ASSETS — 100.0%** |  | **11707483** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<br>Percentages indicated are based on net assets.<br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| **Abbreviations** |  |
| ADR | American Depositary Receipt |
| PT | Limited liability company |
| REIT | Real Estate Investment Trust |
| SGPS | Holding company |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Non-income producing security. 

(a) Security exempt from registration pursuant to Regulation S under the Securities Act of 1933, as amended. Regulation S applies to securities offerings that are made outside of the United States and do not involve direct selling efforts in the United States and as such may have restrictions on resale. 

(b) Investment in an affiliated fund, which is registered under the Investment Company Act of 1940, as amended, and is advised by J.P. Morgan Investment Management Inc. 

(c) The rate shown is the current yield as of January 31, 2023.

------

**JPMorgan Social Advancement ETF** <br>**SCHEDULE OF PORTFOLIO INVESTMENTS** <br>AS OF January 31, 2023 (Unaudited) (continued)

**Summary of Investments by Industry, January 31, 2023**

The following table represents the portfolio investments of the Fund by industry classifications as a percentage of total investments:

---

| | |
|:---|:---|
| **INDUSTRY** | **PERCENT OF** <br>**TOTAL** <br>**INVESTMENTS**<br>|
| Banks | 10.0% |
| Semiconductors & Semiconductor Equipment | &nbsp;&nbsp; 9.2 |
| Food & Staples Retailing | &nbsp;&nbsp; 6.9 |
| IT Services | &nbsp;&nbsp; 6.1 |
| Pharmaceuticals | &nbsp;&nbsp; 5.1 |
| Software | &nbsp;&nbsp; 4.8 |
| Insurance | &nbsp;&nbsp; 4.6 |
| Professional Services | &nbsp;&nbsp; 4.4 |
| Household Durables | &nbsp;&nbsp; 4.2 |
| Biotechnology | &nbsp;&nbsp; 3.8 |
| Health Care Equipment & Supplies | &nbsp;&nbsp; 3.8 |
| Health Care Providers & Services | &nbsp;&nbsp; 3.4 |
| Construction & Engineering | &nbsp;&nbsp; 3.2 |
| Textiles, Apparel & Luxury Goods | &nbsp;&nbsp; 3.0 |
| Equity Real Estate Investment Trusts (REITs) | &nbsp;&nbsp; 2.6 |
| Commercial Services & Supplies | &nbsp;&nbsp; 2.5 |
| Interactive Media & Services | &nbsp;&nbsp; 2.5 |
| Machinery | &nbsp;&nbsp; 2.2 |
| Road & Rail | &nbsp;&nbsp; 2.0 |
| Wireless Telecommunication Services | &nbsp;&nbsp; 2.0 |
| Chemicals | &nbsp;&nbsp; 1.8 |
| Life Sciences Tools & Services | &nbsp;&nbsp; 1.4 |
| Capital Markets | &nbsp;&nbsp; 1.4 |
| Real Estate Management & Development | &nbsp;&nbsp; 1.1 |
| Building Products | &nbsp;&nbsp; 1.1 |
| Multiline Retail | &nbsp;&nbsp; 1.1 |
| Food Products | &nbsp;&nbsp; 1.0 |
| Household Products | &nbsp;&nbsp; 1.0 |
| Others (each less than 1.0%) | &nbsp;&nbsp; 1.3 |
| Short-Term Investments | &nbsp;&nbsp; 2.5 |

---

------

**JPMorgan Social Advancement ETF** <br>**SCHEDULE OF PORTFOLIO INVESTMENTS** <br>AS OF January 31, 2023 (Unaudited) (continued)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**A. Valuation of Investments** — Investments are valued in accordance with U.S. generally accepted accounting principles ("GAAP") and the Fund's valuation policies set forth by, and under the supervision and responsibility of, the Board of Trustees of the Trust (the "Board"), which established the following approach to valuation, as described more fully below: (i) investments for which market quotations are readily available shall be valued at their market value and (ii) all other investments for which market quotations are not readily available shall be valued at their fair value as determined in good faith by the Board.

Under Section 2(a)(41) of the Investment Company Act of 1940, the Board is required to determine fair value for securities that do not have readily available market quotations. Under SEC Rule 2a-5 (Good Faith Determinations of Fair Value), the Board may designate the performance of these fair valuation determinations to a valuation designee. The Board has designated the Adviser as the "Valuation Designee" to perform fair valuation determinations for the Funds on behalf of the Board subject to appropriate oversight by the Board. The Adviser, as Valuation Designee, leverages the J.P. Morgan Asset Management Americas Valuation Committee ("AVC") to help oversee and carry out the policies for the valuation of Investments held in the Funds. The Adviser, as Valuation Designee, remains responsible for the valuation determinations.

This oversight by the AVC includes monitoring the appropriateness of fair values based on results of ongoing valuation oversight including, but not limited to, consideration of macro or security specific events, market events, and pricing vendor and broker due diligence. The Administrator is responsible for discussing and assessing the potential impacts to the fair values on an ongoing basis, and, at least on a quarterly basis, with the AVC and the Board.

Equities and other exchange-traded instruments are valued at the last sale price or official market closing price on the primary exchange on which the instrument is traded before the net asset value ("NAV") of the Fund is calculated on a valuation date. Certain foreign equity instruments are valued by applying international fair value factors provided by approved Pricing Services. The factors seek to adjust the local closing price for movements of local markets post-closing, but prior to the time the NAV is calculated.

Investments in open-end investment companies ("Underlying Funds") are valued at each Underlying Fund's NAVs per share as of the report date.

Valuations reflected in this report are as of the report date. As a result, changes in valuation due to market events and/or issuer-related events after the report date and prior to issuance of the report are not reflected herein.

The various inputs that are used in determining the valuation of the Fund's investments are summarized into the three broad levels listed below.

• Level 1 — Unadjusted inputs using quoted prices in active markets for identical investments.

• Level 2 — Other significant observable inputs including, but not limited to, quoted prices for similar investments, inputs other than quoted prices that are observable for investments (such as interest rates, prepayment speeds, credit risk, etc.) or other market corroborated inputs.

• Level 3 — Significant inputs based on the best information available in the circumstances, to the extent observable inputs are not available (including the Fund's assumptions in determining the fair value of investments).

A financial instrument's level within the fair value hierarchy is based on the lowest level of any input, both individually and in the aggregate, that is significant to the fair value measurement. The inputs or methodology used for valuing instruments are not necessarily an indication of the risk associated with investing in those instruments.

The following table represents each valuation input as presented on the Schedule of Portfolio Investments ("SOI"):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp;&nbsp;&nbsp; **Level 1** <br>Quoted prices<br>| &nbsp;&nbsp;&nbsp;&nbsp; **Level 2** <br>Other significant <br>observable inputs<br>| &nbsp;&nbsp;&nbsp;&nbsp; **Level 3** <br>Significant <br>unobservable inputs<br>| **Total** |
| **Investments in Securities** |  |  |  |  |
| Common Stocks |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Australia | $— | $110955 | $— | $110955 |
| &nbsp;&nbsp;&nbsp; Belgium | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 194649 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 194649 |
| &nbsp;&nbsp;&nbsp; Brazil | &nbsp;&nbsp;&nbsp;&nbsp; 137659 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 137659 |
| &nbsp;&nbsp;&nbsp; China | &nbsp;&nbsp;&nbsp;&nbsp; 212325 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 212325 |
| &nbsp;&nbsp;&nbsp; Denmark | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 275534 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 275534 |
| &nbsp;&nbsp;&nbsp; France | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 375238 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 375238 |
| &nbsp;&nbsp;&nbsp; Germany | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 152321 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 152321 |
| &nbsp;&nbsp;&nbsp; Hong Kong | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 153784 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 153784 |

---

------

**JPMorgan Social Advancement ETF** <br>**SCHEDULE OF PORTFOLIO INVESTMENTS** <br>AS OF January 31, 2023 (Unaudited) (continued)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp;&nbsp;&nbsp; **Level 1**<br> Quoted prices<br>| &nbsp;&nbsp;&nbsp;&nbsp; **Level 2**<br> Other significant<br> observable inputs<br>| &nbsp;&nbsp;&nbsp;&nbsp; **Level 3**<br> Significant<br> unobservable inputs<br>| **Total** |
| &nbsp;&nbsp;&nbsp; India | $304333 | $— | $— | $304333 |
| &nbsp;&nbsp;&nbsp; Indonesia | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 115368 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 115368 |
| &nbsp;&nbsp;&nbsp; Ireland | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 248394 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 248394 |
| &nbsp;&nbsp;&nbsp; Italy | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 222962 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 222962 |
| &nbsp;&nbsp;&nbsp; Japan | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 764231 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 764231 |
| &nbsp;&nbsp;&nbsp; Mexico | &nbsp;&nbsp;&nbsp;&nbsp; 248497 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 248497 |
| &nbsp;&nbsp;&nbsp; Netherlands | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 863538 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 863538 |
| &nbsp;&nbsp;&nbsp; Nigeria | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 121646 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 121646 |
| &nbsp;&nbsp;&nbsp; Peru | &nbsp;&nbsp;&nbsp;&nbsp; 122079 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 122079 |
| &nbsp;&nbsp;&nbsp; Portugal | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 170950 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 170950 |
| &nbsp;&nbsp;&nbsp; Puerto Rico | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 64165 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 64165 |
| &nbsp;&nbsp;&nbsp; South Africa | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 111307 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 111307 |
| &nbsp;&nbsp;&nbsp; Switzerland | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 77856 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 77856 |
| &nbsp;&nbsp;&nbsp; United Kingdom | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 805272 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 805272 |
| &nbsp;&nbsp;&nbsp; United States | &nbsp;&nbsp; 5350011 | &nbsp;&nbsp;&nbsp;&nbsp; 156710 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 5506721 |
| &nbsp;&nbsp;&nbsp; Total Common Stocks | &nbsp;&nbsp; 6439069 | &nbsp;&nbsp; 4920715 | &nbsp;&nbsp; — | &nbsp;&nbsp; 11359784 |
| Short-Term Investments |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Investment Companies | &nbsp;&nbsp;&nbsp;&nbsp; 290481 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 290481 |
| **Total Investments in Securities** | $6729550 | $4920715 | $— | $11650265 |

---

**B. Investment Transactions with Affiliates** — The Fund invested in an Underlying Fund, which is advised by the Adviser. An issuer which is under common control with the Fund may be considered an affiliate. The Fund assumes the issuer listed in the table below to be an affiliated issuer. The Underlying Fund's distributions may be reinvested into such Underlying Fund. Reinvestment amounts are included in the purchases at cost amounts in the table below.

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **For the period ended January 31, 2023** | **For the period ended January 31, 2023** | **For the period ended January 31, 2023** | **For the period ended January 31, 2023** | **For the period ended January 31, 2023** | **For the period ended January 31, 2023** | **For the period ended January 31, 2023** | **For the period ended January 31, 2023** | **For the period ended January 31, 2023** | **For the period ended January 31, 2023** |
| **Security Description** | **Value at** <br>**October 31,** <br>**2022**<br>| **Purchases at** <br>**Cost**<br>| **Proceeds from** <br>**Sales**<br>| **Net Realized** <br>**Gain (Loss)**<br>| **Change in** <br>**Unrealized** <br>**Appreciation/** <br>**(Depreciation)**<br>| **Value at** <br>**January 31,** <br>**2023**<br>| **Shares at** <br>**January 31,** <br>**2023**<br>| **Dividend** <br>**Income**<br>| **Capital Gain** <br>**Distributions**<br>|
| &nbsp;&nbsp;&nbsp; JPMorgan Prime Money Market Fund Class IM <br> Shares, 4.52% (a) (b)<br>| $421937 | $172737 | $304375 | $5 | $177 | $290481 | 290307 | $3558 | $— |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

 <br> (a) Investment in an affiliated fund, which is registered under the Investment Company Act of 1940, as amended, and is advised by J.P. Morgan Investment Management Inc. <br> (b) The rate shown is the current yield as of January 31, 2023.

------

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** J.P. Morgan Exchange-Traded Fund Trust

- **b. Investment Company Act file number:** 811-22903

- **c. CIK number of Registrant:** 0001485894

- **d. LEI of Registrant:** 5493001E1K1DVWDV2464

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 277 Park Avenue

  - **City:** New York

  - **State:** NY

  - **Foreign country:** US

  - **Zip / Postal Code:** 10172

  - **Telephone number:** 844-457-6383

**Item A.2. Information about the Series.**

- **a. Name of Series:** JPMorgan Social Advancement ETF

- **b. EDGAR series identifier (if any):** S000076156

- **c. LEI of Series:** 549300IRETAWBGTPYW54

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2023-10-31

- **b. Date as of which information is reported:** 2023-01-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $11712241.53

**Total Liabilities:** $4744.69

**Net Assets:** $11707496.84

**Cash Not Reported:** $1.38

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000235629 | 8.43%                | -2.94%               | 4.98%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-2949.42                | $887505.22                                 |
| Month 2  | $13765.17                | $-365344.06                                |
| Month 3  | $-10840.52               | $568011.00                                 |

**Designated Index Information**

- **Index Name:** N/A

- **Index Identifier:** N/A

### Schedule of Portfolio Investments

| Name                                  | Title                                      | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Alphabet, Inc.                        | Alphabet, Inc., Class A                    | CUSIP: 02079K305<br>LEI: 5493006MHB84DD0ZWV18 | Long             | EC               | CORP              | US        |      2907 | NS      | $287327.88    | 2.45%             |  |  |  | No            |                  1 | On Loan: No      |
| T&D Holdings, Inc.                    | T&D Holdings, Inc.                         | CUSIP: N/A<br>LEI: 3538008ARJ1MACEWA242       | Long             | EC               | CORP              | JP        |      9900 | NS      | $158461.96    | 1.35%             |  |  |  | No            |                  2 | On Loan: No      |
| Vodacom Group Ltd.                    | Vodacom Group Ltd.                         | CUSIP: N/A<br>LEI: 37890012A8DC24B8D663       | Long             | EC               | CORP              | ZA        |     15838 | NS      | $111307.20    | 0.95%             |  |  |  | No            |                  2 | On Loan: No      |
| Katitas Co. Ltd.                      | Katitas Co. Ltd.                           | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | JP        |      5400 | NS      | $132410.39    | 1.13%             |  |  |  | No            |                  2 | On Loan: No      |
| NN Group NV                           | NN Group NV                                | CUSIP: N/A<br>LEI: 724500OHYNDT9OY6Q215       | Long             | EC               | CORP              | NL        |      2520 | NS      | $109489.15    | 0.94%             |  |  |  | No            |                  2 | On Loan: No      |
| Boston Scientific Corp.               | Boston Scientific Corp.                    | CUSIP: 101137107<br>LEI: Y6ZDD9FP4P8JSSJMW954 | Long             | EC               | CORP              | US        |      5329 | NS      | $246466.25    | 2.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Jeronimo Martins SGPS SA              | Jeronimo Martins SGPS SA                   | CUSIP: N/A<br>LEI: 259400A8SZP10GB5IB19       | Long             | EC               | CORP              | PT        |      7874 | NS      | $170950.25    | 1.46%             |  |  |  | No            |                  2 | On Loan: No      |
| Fiserv, Inc.                          | Fiserv, Inc.                               | CUSIP: 337738108<br>LEI: GI7UBEJLXYLGR2C7GV83 | Long             | EC               | CORP              | US        |      1134 | NS      | $120975.12    | 1.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Recruit Holdings Co. Ltd.             | Recruit Holdings Co. Ltd.                  | CUSIP: N/A<br>LEI: 353800R2LRSMVVC4I806       | Long             | EC               | CORP              | JP        |      3800 | NS      | $122209.00    | 1.04%             |  |  |  | No            |                  2 | On Loan: No      |
| Raia Drogasil SA                      | Raia Drogasil SA                           | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | BR        |     28008 | NS      | $137659.24    | 1.18%             |  |  |  | No            |                  1 | On Loan: No      |
| adidas AG                             | adidas AG                                  | CUSIP: N/A<br>LEI: 549300JSX0Z4CW0V5023       | Long             | EC               | CORP              | DE        |       946 | NS      | $152321.36    | 1.30%             |  |  |  | No            |                  2 | On Loan: No      |
| Sika AG                               | Sika AG (Registered)                       | CUSIP: N/A<br>LEI: 549300R3N69ECGYPU434       | Long             | EC               | CORP              | CH        |       274 | NS      | $77856.24     | 0.67%             |  |  |  | No            |                  2 | On Loan: No      |
| Sun Communities, Inc.                 | Sun Communities, Inc.                      | CUSIP: 866674104<br>LEI: 549300H5GEOJYN41ZG57 | Long             | EC               | CORP              | US        |      1233 | NS      | $193408.38    | 1.65%             |  |  |  | No            |                  1 | On Loan: No      |
| Mastercard, Inc.                      | Mastercard, Inc., Class A                  | CUSIP: 57636Q104<br>LEI: AR5L2ODV9HN37376R084 | Long             | EC               | CORP              | US        |       747 | NS      | $276838.20    | 2.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Vinci SA                              | Vinci SA                                   | CUSIP: N/A<br>LEI: 213800WFQ334R8UXUG83       | Long             | EC               | CORP              | FR        |      3321 | NS      | $375238.39    | 3.21%             |  |  |  | No            |                  2 | On Loan: No      |
| RELX plc                              | RELX plc                                   | CUSIP: N/A<br>LEI: 549300WSX3VBUFFJOO66       | Long             | EC               | CORP              | GB        |     13046 | NS      | $387582.81    | 3.31%             |  |  |  | No            |                  2 | On Loan: No      |
| Skyline Champion Corp.                | Skyline Champion Corp.                     | CUSIP: 830830105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2709 | NS      | $159695.55    | 1.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Tokyo Electron Ltd.                   | Tokyo Electron Ltd.                        | CUSIP: N/A<br>LEI: 549300H5LSF8DP3RIJ34       | Long             | EC               | CORP              | JP        |       500 | NS      | $174762.16    | 1.49%             |  |  |  | No            |                  2 | On Loan: No      |
| Dollar General Corp.                  | Dollar General Corp.                       | CUSIP: 256677105<br>LEI: OPX52SQVOZI8IVSWYU66 | Long             | EC               | CORP              | US        |       537 | NS      | $125443.20    | 1.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Wal-Mart de Mexico SAB de CV          | Wal-Mart de Mexico SAB de CV               | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | MX        |     63621 | NS      | $248497.10    | 2.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Deere & Co.                           | Deere & Co.                                | CUSIP: 244199105<br>LEI: PWFTNG3EI0Y73OXWDH08 | Long             | EC               | CORP              | US        |       612 | NS      | $258778.08    | 2.21%             |  |  |  | No            |                  1 | On Loan: No      |
| EVERTEC, Inc.                         | EVERTEC, Inc.                              | CUSIP: 30040P103<br>LEI: N/A                  | Long             | EC               | CORP              | PR        |      1737 | NS      | $64164.78     | 0.55%             |  |  |  | No            |                  1 | On Loan: No      |
| LITALICO, Inc.                        | LITALICO, Inc.                             | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | JP        |      3100 | NS      | $63285.95     | 0.54%             |  |  |  | No            |                  2 | On Loan: No      |
| Bank Rakyat Indonesia Persero Tbk. PT | Bank Rakyat Indonesia Persero Tbk. PT      | CUSIP: N/A<br>LEI: 254900HB6S4B12GBNP64       | Long             | EC               | CORP              | ID        |    376200 | NS      | $115368.48    | 0.99%             |  |  |  | No            |                  2 | On Loan: No      |
| Airtel Africa plc                     | Airtel Africa plc                          | CUSIP: N/A<br>LEI: 254900ZNZDQL6OWQH623       | Long             | EC               | CORP              | GB        |     84262 | NS      | $121645.94    | 1.04%             |  |  |  | Yes           |                  2 | On Loan: No      |
| Koninklijke Ahold Delhaize NV         | Koninklijke Ahold Delhaize NV              | CUSIP: N/A<br>LEI: 724500C9GNBV20UYRX36       | Long             | EC               | CORP              | NL        |      8075 | NS      | $241014.29    | 2.06%             |  |  |  | No            |                  2 | On Loan: No      |
| ASML Holding NV                       | ASML Holding NV                            | CUSIP: N/A<br>LEI: 724500Y6DUVHQD6OXN27       | Long             | EC               | CORP              | NL        |       568 | NS      | $375815.79    | 3.21%             |  |  |  | No            |                  2 | On Loan: No      |
| Reckitt Benckiser Group plc           | Reckitt Benckiser Group plc                | CUSIP: N/A<br>LEI: 5493003JFSMOJG48V108       | Long             | EC               | CORP              | GB        |      1557 | NS      | $110953.28    | 0.95%             |  |  |  | No            |                  2 | On Loan: No      |
| Kingspan Group plc                    | Kingspan Group plc                         | CUSIP: N/A<br>LEI: 635400HM7V74SUB9OG75       | Long             | EC               | CORP              | IE        |      2041 | NS      | $131269.07    | 1.12%             |  |  |  | No            |                  2 | On Loan: No      |
| Koninklijke DSM NV                    | Koninklijke DSM NV                         | CUSIP: N/A<br>LEI: 724500SNT1MK246AHP04       | Long             | EC               | CORP              | NL        |      1067 | NS      | $137218.32    | 1.17%             |  |  |  | No            |                  2 | On Loan: No      |
| Stockland                             | Stockland                                  | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | AU        |     39708 | NS      | $110954.86    | 0.95%             |  |  |  | No            |                  2 | On Loan: No      |
| Novo Nordisk A/S                      | Novo Nordisk A/S, Class B                  | CUSIP: N/A<br>LEI: 549300DAQ1CVT6CXN342       | Long             | EC               | CORP              | DK        |      1991 | NS      | $275534.25    | 2.35%             |  |  |  | No            |                  2 | On Loan: No      |
| Vertex Pharmaceuticals, Inc.          | Vertex Pharmaceuticals, Inc.               | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |       681 | NS      | $220031.10    | 1.88%             |  |  |  | No            |                  1 | On Loan: No      |
| Analog Devices, Inc.                  | Analog Devices, Inc.                       | CUSIP: 032654105<br>LEI: GYVOE5EZ4GDAVTU4CQ61 | Long             | EC               | CORP              | US        |       909 | NS      | $155866.23    | 1.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Roche Holding AG                      | Roche Holding AG                           | CUSIP: N/A<br>LEI: 549300U41AUUVOAAOB37       | Long             | EC               | CORP              | CH        |       502 | NS      | $156709.55    | 1.34%             |  |  |  | No            |                  2 | On Loan: No      |
| Charles Schwab Corp. (The)            | Charles Schwab Corp. (The)                 | CUSIP: 808513105<br>LEI: 549300VSGCJ7E698NM85 | Long             | EC               | CORP              | US        |      2043 | NS      | $158169.06    | 1.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Tokio Marine Holdings, Inc.           | Tokio Marine Holdings, Inc.                | CUSIP: N/A<br>LEI: 5299009QN2NZ191KLS29       | Long             | EC               | CORP              | JP        |      5400 | NS      | $113101.46    | 0.97%             |  |  |  | No            |                  2 | On Loan: No      |
| HDFC Bank Ltd.                        | HDFC Bank Ltd.                             | CUSIP: 40415F101<br>LEI: 335800ZQ6I4E2JXENC50 | Long             | EC               | CORP              | IN        |      4518 | NS      | $304332.48    | 2.60%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca plc                       | AstraZeneca plc                            | CUSIP: N/A<br>LEI: PY6ZZQWO2IZFZC3IOL08       | Long             | EC               | CORP              | GB        |      1203 | NS      | $157608.10    | 1.35%             |  |  |  | No            |                  2 | On Loan: No      |
| Microsoft Corp.                       | Microsoft Corp.                            | CUSIP: 594918104<br>LEI: INR2EJN1ERAN0W5ZP974 | Long             | EC               | CORP              | US        |      2248 | NS      | $557076.88    | 4.76%             |  |  |  | No            |                  1 | On Loan: No      |
| NIKE, Inc.                            | NIKE, Inc., Class B                        | CUSIP: 654106103<br>LEI: 787RXPR0UX0O0XUXPZ81 | Long             | EC               | CORP              | US        |      1580 | NS      | $201181.40    | 1.72%             |  |  |  | No            |                  1 | On Loan: No      |
| JPMorgan Prime Money Market Fund      | JPMorgan Prime Money Market Fund, Class IM | CUSIP: 46637K844<br>LEI: N/A                  | Long             | STIV             | RF                | US        |    403331 | NS      | $403572.50    | 3.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Kerry Group plc                       | Kerry Group plc, Class A                   | CUSIP: N/A<br>LEI: 635400TLVVBNXLFHWC59       | Long             | EC               | CORP              | IE        |      1250 | NS      | $117125.10    | 1.00%             |  |  |  | No            |                  2 | On Loan: No      |
| Waste Connections, Inc.               | Waste Connections, Inc.                    | CUSIP: 94106B101<br>LEI: 549300HDLRTPBQU69P29 | Long             | EC               | CORP              | CA        |      2215 | NS      | $294373.50    | 2.51%             |  |  |  | No            |                  1 | On Loan: No      |
| AIA Group Ltd.                        | AIA Group Ltd.                             | CUSIP: N/A<br>LEI: ZP5ILWVSYE4LJGMMVD57       | Long             | EC               | CORP              | HK        |     13600 | NS      | $153784.01    | 1.31%             |  |  |  | No            |                  2 | On Loan: No      |
| KBC Group NV                          | KBC Group NV                               | CUSIP: N/A<br>LEI: 213800X3Q9LSAKRUWY91       | Long             | EC               | CORP              | BE        |      2628 | NS      | $194648.92    | 1.66%             |  |  |  | No            |                  2 | On Loan: No      |
| Intuitive Surgical, Inc.              | Intuitive Surgical, Inc.                   | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |       811 | NS      | $199254.59    | 1.70%             |  |  |  | No            |                  1 | On Loan: No      |
| AbbVie, Inc.                          | AbbVie, Inc.                               | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |      1530 | NS      | $226057.50    | 1.93%             |  |  |  | No            |                  1 | On Loan: No      |
| Union Pacific Corp.                   | Union Pacific Corp.                        | CUSIP: 907818108<br>LEI: 549300LMMRSZZCZ8CL11 | Long             | EC               | CORP              | US        |       720 | NS      | $147016.80    | 1.26%             |  |  |  | No            |                  1 | On Loan: No      |
| NXP Semiconductors NV                 | NXP Semiconductors NV                      | CUSIP: N/A<br>LEI: 724500M9BY5293JDF951       | Long             | EC               | CORP              | NL        |      1152 | NS      | $212325.12    | 1.81%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group, Inc.              | UnitedHealth Group, Inc.                   | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |       798 | NS      | $398353.62    | 3.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Pathward Financial, Inc.              | Pathward Financial, Inc.                   | CUSIP: 59100U108<br>LEI: 5493004X52BH1NBLW813 | Long             | EC               | CORP              | US        |      1854 | NS      | $91995.48     | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Thermo Fisher Scientific, Inc.        | Thermo Fisher Scientific, Inc.             | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |       278 | NS      | $158551.74    | 1.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Credicorp Ltd.                        | Credicorp Ltd.                             | CUSIP: N/A<br>LEI: 529900UYAEYQCQ2BKB17       | Long             | EC               | CORP              | BM        |       909 | NS      | $122078.70    | 1.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Visa, Inc.                            | Visa, Inc., Class A                        | CUSIP: 92826C839<br>LEI: 549300JZ4OKEHW3DPJ59 | Long             | EC               | CORP              | US        |      1075 | NS      | $247475.75    | 2.11%             |  |  |  | No            |                  1 | On Loan: No      |
| FinecoBank Banca Fineco SpA           | FinecoBank Banca Fineco SpA                | CUSIP: N/A<br>LEI: 549300L7YCATGO57ZE10       | Long             | EC               | CORP              | IT        |     12420 | NS      | $222962.10    | 1.90%             |  |  |  | No            |                  2 | On Loan: No      |
| Lam Research Corp.                    | Lam Research Corp.                         | CUSIP: 512807108<br>LEI: 549300I4GMO6D34U1T02 | Long             | EC               | CORP              | US        |       304 | NS      | $152030.40    | 1.30%             |  |  |  | No            |                  1 | On Loan: No      |
| M&T Bank Corp.                        | M&T Bank Corp.                             | CUSIP: 55261F104<br>LEI: 549300WYXDDBYRASEG81 | Long             | EC               | CORP              | US        |       690 | NS      | $107640.00    | 0.92%             |  |  |  | No            |                  1 | On Loan: No      |
| SLM Corp.                             | SLM Corp.                                  | CUSIP: 78442P106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5463 | NS      | $95984.91     | 0.82%             |  |  |  | No            |                  1 | On Loan: No      |
| DR Horton, Inc.                       | DR Horton, Inc.                            | CUSIP: 23331A109<br>LEI: 529900ZIUEYVSB8QDD25 | Long             | EC               | CORP              | US        |      1845 | NS      | $182083.05    | 1.56%             |  |  |  | No            |                  1 | On Loan: No      |
| CSX Corp.                             | CSX Corp.                                  | CUSIP: 126408103<br>LEI: 549300JVQR4N1MMP3Q88 | Long             | EC               | CORP              | US        |      2844 | NS      | $87936.48     | 0.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Taylor Wimpey plc                     | Taylor Wimpey plc                          | CUSIP: N/A<br>LEI: 21380089BTRXTD8S3R66       | Long             | EC               | CORP              | GB        |    102781 | NS      | $149127.37    | 1.27%             |  |  |  | No            |                  2 | On Loan: No      |

### Signature

**Date Signed:** 2023-03-02

**Name of Applicant:** J.P. Morgan Exchange-Traded Fund Trust

**Signature:** Timothy J. Clemens

**Name of Signer:** Timothy J. Clemens

**Title:** Treasurer and Principal Financial Officer